Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours

Journal of Oral Pathology and Medicine

Volumn 37, Issue 5, 2008, Pages 309-318

  Vargas, P A ^a,b   Cheng, Y ^a   Barrett, A W ^c   Craig, G T ^a   Speight, P M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Geminin; Immunohistochemistry; Ki 67; Mcm 2; Salivary gland tumours; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; GEMININ; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; TUMOR MARKER;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA EX PLEOMORPHIC ADENOMA; CELL LABELING; CELL PROLIFERATION; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PLEOMORPHIC ADENOMA; POLYMORPHOUS LOW GRADE ADENOCARCINOMA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; TISSUE MICROARRAY;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ACINAR CELL; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CELL CYCLE PROTEINS; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149136945     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00631.x     Document Type: Article

References (41)

1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002 8 : 229 40.
2. Jones AV, Franklin CD. An analysis of oral and maxillofacial pathology found in adults over a 30-year period. J Oral Pathol Med 2006 35 : 392 401.
3. Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA. Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg 2005 34 : 533 6.
4. Vargas PA, Gerhard R, Araújo Filho VJ, de Castro IV. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo 2002 57 : 271 6.
5. Lopes MA, Kowalski LP, Santos GC, Almeida OP. A clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Pathol Med 1999 28 : 264 7.
6. Forsburg SL. Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev 2004 68 : 109 31.
7. Maine GT, Sinha P, Tye BK. Mutants of S. cerevisiae defective in the maintenance of minichromosomes. Genetics 1984 106 : 365 85.
8. Blow JJ, Laskey RA. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature 1988 332 : 546 8.
9. Hennessy KM, Clark CD, Botstein D. Subcellular localization of yeast CDC46 varies with the cell cycle. Genes Dev 1990 4 : 2252 63.
10. Blow JJ, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 2005 6 : 476 86.
11. Alison MR, Hunt T, Forbes SJ. Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 2002 50 : 290 1.
12. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991 138 : 867 73.
13. Hodgson B, Li A, Tada S, Blow JJ. Geminin becomes activated as an inhibitor of Cdt1/RLF-B following nuclear import. Curr Biol 2002 12 : 678 83.
14. Wohlschlegel JA, Kutok JL, Weng AP, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol 2002 161 : 267 73.
15. Gonzalez MA, Tachibana KE, Chin SF, et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 2004 204 : 121 30.
16. Alves FA, Pires FR, Almeida OP, Lopes MA, Kowalski LP. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 2004 33 : 593 7.
17. da Cruz Perez DE, Pires FR, Alves FA, Almeida OP, Kowalski LP. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases. Int J Pediatr Otorhinolaryngol 2004 68 : 895 902.
18. Going JJ, Keith WN, Neilson L, Stoeber K, Stuart RC, Williams GH. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 2002 50 : 373 7.
19. Gonzalez MA, Pinder SE, Callagy G, et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 2003 21 : 4306 13.
20. Meng MV, Grossfeld GD, Williams GH, et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 2001 7 : 2712 8.
21. Rodins K, Cheale M, Coleman N, Fox SB. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res 2002 8 : 1075 81.
22. Kodani I, Osaki M, Shomori K, et al. Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. J Oral Pathol Med 2003 32 : 468 74.
23. Dudderidge TJ, Stoeber K, Loddo M, et al. Mcm-2, geminin, and KI-67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 2005 11 : 2510 7.
24. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999 5 : 2121 32.
25. Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon : IARC Press, 2005 210.
26. Quaglia A, McStay M, Stoeber K, et al. Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma. Liver Int 2006 26 : 424 32.
27. Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, et al. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res 2006 26 : 2473 8.
28. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984 133 : 1710 5.
29. Shetty A, Loddo M, Fanshawe T, et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 2005 93 : 1295 300.
30. Korkolopoulou P, Givalos N, Saetta A, et al. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol 2005 36 : 899 907.
31. Beltran D, Faquin WC, Gallagher G, August M. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 2006 64 : 415 23.
32. Skalova A, Simpson RH, Lehtonen H, Leivo I. Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract 1997 193 : 695 703.
33. Layfield LJ, Tan P, Glasgow BJ. Fine-needle aspiration of salivary gland lesions. Comparison with frozen sections and histologic findings. Arch Pathol Lab Med 1987 111 : 346 53.
34. Pinto AE, Fonseca I, Soares J. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases. Cancer 1999 85 : 273 81.
35. Driemel O, Maier H, Kraft K, Haase S, Hemmer J. Flow cytometric DNA ploidy in salivary gland tumours. Oncol Rep 2005 13 : 161 5.
36. Vargas PA, Torres-Rendon A, Speight PM. DNA ploidy analysis in salivary gland tumours by image cytometry. J Oral Pathol Med 2007 36 : 371 6.
37. Kiyoshima T, Shima K, Kobayashi I, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 2001 37 : 315 22.
38. Cho KJ, Lee SS, Lee YS. Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 1999 21 : 414 9.
39. Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R. Carcinoma of the parotid and submandibular glands - a study of survival in 2465 patients. Oral Oncol 2002 38 : 706 13.
40. Tzankov A, Went P, Zimpfer A, Dirnhofer S. Tissue microarray technology: principles, pitfalls and perspectives - lessons learned from hematological malignancies. Exp Gerontol 2005 40 : 737 44.
41. Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001 195 : 72 9.